Alzheon’s new Alzheimer’s ALZ-801 drug is finishing up recruiting for Phase 3 clinical trials. If the trial proves successful, it may become the first…
A new study reveals that Asian, Black, and Hispanic patients are less likely to develop beta-amyloid plaques — a key Alzheimer’s biomarker — alongside…
Reporter Phil Gutis, a board member for emerging Alzheimer’s advocacy group Voices of Alzheimer’s, takes a hard look at what more the Centers for…
How much does Aduhelm cost? Even if you can cover the expense, that doesn’t mean the drug is easy to get. Aduhelm costs an…
The journey to an Alzheimer’s diagnosis can be arduous for people experiencing early symptoms. For Doug and Michele Hall, it meant several trips to…
Bombshell exposé in Science magazine and follow-up reporting “make a mountain out of a molehill,” leading Alzheimer’s experts say. The media is reporting that…
Biogen and Eisai’s next disease-modifying Alzheimer’s drug candidate, lecanemab, has been granted FDA priority review, signaling that a decision could be made by early…